PodParley PodParley

Season 6 / Ep. 1 (March 2026) - Modern United Way Leadership: Moving From Charity to Systems Change

Episode 1 of the United for Impact - Stories of Change, Progress, and the People Making it Happen podcast, hosted by United Way of Delaware, titled "Season 6 / Ep. 1 (March 2026) - Modern United Way Leadership: Moving From Charity to Systems Change" was published on March 30, 2026 and runs 18 minutes.

March 30, 2026 ·18m · United for Impact - Stories of Change, Progress, and the People Making it Happen

0:00 / 0:00

On this month's podcast, Michelle Taylor, President and CEO of United Way of Delaware leads a conversation diving into modern United Way Leadership, the shift from charity to systems change, and how local leaders can align around measurable outcomes. For this important conversation, Michelle is joined by Rodney Prunty, President and CEO of United Way of North Central New Mexico. United Way of Delaware brings together people, organizations, and resources to address the challenges caused by lon...

On this month's podcast, Michelle Taylor, President and CEO of United Way of Delaware leads a conversation diving into modern United Way Leadership, the shift from charity to systems change, and how local leaders can align around measurable outcomes. For this important conversation, Michelle is joined by Rodney Prunty, President and CEO of United Way of North Central New Mexico.

United Way of Delaware brings together people, organizations, and resources to address the challenges caused by long-standing disparities. In partnership with passionate community leaders, we are dedicated to creating opportunities that empower men, women, and children across Delaware and Salem County, New Jersey. Our mission is to help families move from crisis to thriving, ensuring every child gets a strong start by reading at grade level. We are committed to equipping the next generation with the skills they need to become the workforce our state needs to flourish, while also ensuring families have access to livable wages that support their success and stability. Together, we’re building a stronger, more vibrant future for all.

Support the show

Founder's Focus Gary Beach For more than 25 years, TECH CORPS has worked to ensure K through 12th grade students in the United States have equal access to technology programs, skills and resources that enhance early learning and prepare them for college or career.Founder’s Focus invites you along for the journey as we examine technology and how it impacts the way we work and live. Agenda 559 Podcast Agenda 559 Our mission is to unite, educate and inspire our communities, provide insight, opportunity and conversations that will impact the world in positive, constructive manner. Agenda 559 stands as an outlet for people and talents of the Central Valley to be heard and expressed. Together we can build a better tomorrow. Support this podcast: https://anchor.fm/thaddis-johnson-jr/support SCREAM with Ryan C. Showers SCREAM with Ryan C. Showers "SCREAM with Ryan C. Showers" is podcast show that explores the Scream film franchise in deep, focused analysis. It is the goal of this show to unite the engaging, film critic analysis with a fan's passion and love for the mythology of Scream. This podcast aims to give equal airtime to Scream (1996), Scream 2, Scream 3, Scream 4, Scream (2022), Scream 6, and the upcoming Scream 7, as well as Scream-adjacent topics. Episode coverage will include character development, storylines, themes, symbolism, filmmaking techniques and craftsmanship, the horror genre, cinematic legacies, comparative discussions, and cultural impacts. In addition, "SCREAM with Ryan C. Showers" will provide coverage and discourse of news about upcoming installments in the movie series. Exploring Best Practices for Diagnosis & Management of Adult-Onset Still's Disease AOSD Podcast Adult-onset Still’s disease (AOSD) is a rare, polygenic autoinflammatory syndrome with a pathogenesis similar to systemic juvenile inflammatory arthritis. Join Drs. Petros Efthimiou and Olga Petryna as they discuss making the diagnosis of AOSD through interpretation of clinical and laboratory findings and careful exclusion of other diseases. The faculty review the evidence related to the variety of medications often used to treat patients with AOSD, focusing on canakinumab, the only medication approved in the United States for the disease.
URL copied to clipboard!